Economic Evaluation of Enoxaparin for Anticoagulation in Early Cardioversion of Persisting Nonvalvular Atrial Fibrillation: A Statutory Health Insurance Perspective from Germany

Author： Schädlich Peter K.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.3, 2007-01, pp. : 199-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective

By Peter K. Schädlich  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 955-973

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Ramipril in Heart Failure after Myocardial Infarction: Economic Evaluation of the Acute Infarction Ramipril Efficacy (AIRE) Study for Germany from the Perspective of Statutory Health Insurance

By Schädlich P.K.  

PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. : 653-669

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance

By Schädlich P.K.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 497-512

Adis International

Access to resources Recommend Favorite

Anticoagulation for Non‐Valvular Atrial Fibrillation in Older People

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 3, 2012-09 ,pp. : 228-234

John Wiley & Sons Inc

Access to resources Recommend Favorite

The hidden costs of anticoagulation in hospitalized patients with non-valvular atrial fibrillation

By Burnett Allison   Tiongson Jay   Downey Ross   Mahan Charles E  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1119-1133

Informa Healthcare

Access to resources Recommend Favorite